Find Methoxyflurane manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

0

Listed Suppliers

Other Suppliers

API REF. PRICE (USD/KG)

$
$ 0

MARKET PLACE

0

API

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

Europe

Europe

0

Listed Dossiers

Listed Dossiers

0 DRUGS IN DEVELOPMENT

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

JP

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Finished Drug Prices

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 76-38-0, Methoxyfluran, Penthrane, Methoflurane, Anecotan, 2,2-dichloro-1,1-difluoroethyl methyl ether
Molecular Formula
C3H4Cl2F2O
Molecular Weight
164.96  g/mol
InChI Key
RFKMCNOHBTXSMU-UHFFFAOYSA-N
FDA UNII
30905R8O7B

Methoxyflurane
An inhalation anesthetic. Currently, methoxyflurane is rarely used for surgical, obstetric, or dental anesthesia. If so employed, it should be administered with NITROUS OXIDE to achieve a relatively light level of anesthesia, and a neuromuscular blocking agent given concurrently to obtain the desired degree of muscular relaxation. (From AMA Drug Evaluations Annual, 1994, p180)
1 2D Structure

Methoxyflurane

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
2,2-dichloro-1,1-difluoro-1-methoxyethane
2.1.2 InChI
InChI=1S/C3H4Cl2F2O/c1-8-3(6,7)2(4)5/h2H,1H3
2.1.3 InChI Key
RFKMCNOHBTXSMU-UHFFFAOYSA-N
2.1.4 Canonical SMILES
COC(C(Cl)Cl)(F)F
2.2 Other Identifiers
2.2.1 UNII
30905R8O7B
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Anecotan

2. Methofluranum

3. Penthrane

4. Pentrane

2.3.2 Depositor-Supplied Synonyms

1. 76-38-0

2. Methoxyfluran

3. Penthrane

4. Methoflurane

5. Anecotan

6. 2,2-dichloro-1,1-difluoroethyl Methyl Ether

7. Metoxifluran

8. Analgizer

9. Metoxfluran

10. Inhalan

11. 2,2-dichloro-1,1-difluoro-1-methoxyethane

12. Methoxane

13. Metofane

14. Pentrane

15. Methofane

16. Pentran

17. Methoxiflurane

18. Methoxifluranum

19. Ingalan

20. Methoxyfluoran

21. Metossiflurano [dcit]

22. Methoxyfluranum

23. Metoxiflurano

24. Ethane, 2,2-dichloro-1,1-difluoro-1-methoxy-

25. Methoxyfluranum [inn-latin]

26. Metoxiflurano [inn-spanish]

27. Nsc-110432

28. Methyl 1,1-difluoro-2,2-dichloroethyl Ether

29. Penthrox

30. (2,2-dichloro-1,1-difluoroethyl) Methyl Ether

31. Ether, 2,2-dichloro-1,1-difluoroethyl Methyl

32. Da-759

33. Chebi:6843

34. 2,2-dichloro-1,1-difluoroethylmethylether

35. 30905r8o7b

36. Penthrane (van)

37. Metofane (van)

38. Ncgc00168747-01

39. Metossiflurano

40. Penthrane (tn)

41. Ccris 5840

42. Hsdb 7201

43. Einecs 200-956-0

44. Methoxyflurane (usp/inn)

45. Methoxyflurane [anaesthetics, Volatile]

46. Brn 1737766

47. Methoxy Flurane

48. Unii-30905r8o7b

49. Methoxyflurane [usan:usp:inn:ban]

50. Wln: Gygxffo1

51. Dsstox_cid_5556

52. Methoxyflurane [mi]

53. Chembl1341

54. Dsstox_rid_77827

55. Methoxyflurane [inn]

56. Dsstox_gsid_25556

57. Methoxyflurane [hsdb]

58. Methoxyflurane [usan]

59. Methoxy Flurane [jan]

60. Methoxyflurane [vandf]

61. Schembl121229

62. 2,1-difluoro-1-methoxyethane

63. Methoxyflurane [mart.]

64. 2,1-difluoroethyl Methyl Ether

65. Gtpl7234

66. Methoxyflurane [usp-rs]

67. Methoxyflurane [who-dd]

68. Dtxsid7025556

69. Zinc896988

70. Methoxyflurane [green Book]

71. Hy-b0718

72. Tox21_112626

73. Mfcd00040144

74. Nsc110432

75. Methoxyflurane [usp Monograph]

76. Akos006228995

77. Db01028

78. Ks-5167

79. Cas-76-38-0

80. Ether,2-dichloro-1,1-difluoroethyl Methyl

81. Db-019611

82. Cs-0009624

83. Ethane,2-dichloro-1,1-difluoro-1-methoxy-

84. Benzenepropanoic Acid, 4-methoxy-.alpha.-oxo-

85. C07517

86. D00544

87. Q411594

88. Sr-01000944693

89. Sr-01000944693-1

2.4 Create Date
2005-03-25
3 Chemical and Physical Properties
Molecular Weight 164.96 g/mol
Molecular Formula C3H4Cl2F2O
XLogP32.2
Hydrogen Bond Donor Count0
Hydrogen Bond Acceptor Count3
Rotatable Bond Count2
Exact Mass163.9607265 g/mol
Monoisotopic Mass163.9607265 g/mol
Topological Polar Surface Area9.2 Ų
Heavy Atom Count8
Formal Charge0
Complexity75.7
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Drug and Medication Information
4.1 Therapeutic Uses

Anesthetic (inhalation).

O'Neil, M.J. (ed.). The Merck Index - An Encyclopedia of Chemicals, Drugs, and Biologicals. 13th Edition, Whitehouse Station, NJ: Merck and Co., Inc., 2001., p. 1073


(VET): Anesthetic.

O'Neil, M.J. (ed.). The Merck Index - An Encyclopedia of Chemicals, Drugs, and Biologicals. 13th Edition, Whitehouse Station, NJ: Merck and Co., Inc., 2001., p. 1073


... Methoxyflurane /is/ indicated for the induction and maintenance of general anesthesia . However, inhalation anesthetic agents are rarely used alone; other medications are frequently administered to induce or supplement anesthesia. /Included in US product labeling/

Thomson.Micromedex. Drug Information for the Health Care Professional. 24th ed. Volume 1. Plus Updates. Content Reviewed by the United States Pharmacopeial Convention, Inc. Greenwood Village, CO. 2004.


... Methoxyflurane ... /is/ indicated in low doses to provide analgesia for procedures not requiring loss of consciousness. /Included in US product labeling/

Thomson.Micromedex. Drug Information for the Health Care Professional. 24th ed. Volume 1. Plus Updates. Content Reviewed by the United States Pharmacopeial Convention, Inc. Greenwood Village, CO. 2004.


For more Therapeutic Uses (Complete) data for METHOXYFLURANE (6 total), please visit the HSDB record page.


4.2 Drug Warning

Inhalation anesthetics cross the placenta. Risk-benefit must be considered because studies (by retrospective survey) of operating room personnel chronically exposed to low concentrations of inhalation anesthetics indicate that pregnancies in female personnel and wives of male personnel may be subject to an increased incidence of spontaneous abortions, stillbirths, and possibly birth defects . However, the methods used in obtaining and interpreting the data in these studies have been questioned. /Inhalation anesthetics/

Thomson.Micromedex. Drug Information for the Health Care Professional. 24th ed. Volume 1. Plus Updates. Content Reviewed by the United States Pharmacopeial Convention, Inc. Greenwood Village, CO. 2004.


Because of potential nephrotoxicity, administration of methoxyflurane in concentrations sufficient to produce muscle relaxation is not recommended ; a neuromuscular blocking agent should be used concurrently if necessary. Also, it is recommended that methoxyflurane not be used during vascular surgery at or near renal blood vessels.

Thomson.Micromedex. Drug Information for the Health Care Professional. 24th ed. Volume 1. Plus Updates. Content Reviewed by the United States Pharmacopeial Convention, Inc. Greenwood Village, CO. 2004.


Caution needed in diabetes, uncontrolled or with polyuria or obesity; in renal function impairment of disease; or in toxemia of pregnancy, as methoxyflurane may increase the risk of nephrotoxicity.

Thomson.Micromedex. Drug Information for the Health Care Professional. 24th ed. Volume 1. Plus Updates. Content Reviewed by the United States Pharmacopeial Convention, Inc. Greenwood Village, CO. 2004.


Monitoring of renal function may be needed to detect possible nephrotoxicity if patient's postoperative urine output is excessive.

Thomson.Micromedex. Drug Information for the Health Care Professional. 24th ed. Volume 1. Plus Updates. Content Reviewed by the United States Pharmacopeial Convention, Inc. Greenwood Village, CO. 2004.


Methoxyflurane, a general anesthetic, is a known nephrotoxin. A case is presented that demonstrated diffuse, bilateral renal cortical calcification on CT secondary to repeated methoxyflurane inhalation.

PMID:3335658 Brennan RP et al; J Comput Assist Tomogr 12 (1): 155-6 (1988)


4.3 Drug Indication

For use in the induction and maintenance of general anesthesia


Treatment of acute pain


5 Pharmacology and Biochemistry
5.1 Pharmacology

Methoxyflurane is a general inhalation anesthetic used for induction and maintenance of general anesthesia. It induces muscle relaxation and reduces pains sensitivity by altering tissue excitability. It does so by decreasing the extent of gap junction mediated cell-cell coupling and altering the activity of the channels that underlie the action potential.


5.2 MeSH Pharmacological Classification

Anesthetics, Inhalation

Gases or volatile liquids that vary in the rate at which they induce anesthesia; potency; the degree of circulation, respiratory, or neuromuscular depression they produce; and analgesic effects. Inhalation anesthetics have advantages over intravenous agents in that the depth of anesthesia can be changed rapidly by altering the inhaled concentration. Because of their rapid elimination, any postoperative respiratory depression is of relatively short duration. (From AMA Drug Evaluations Annual, 1994, p173) (See all compounds classified as Anesthetics, Inhalation.)


5.3 ATC Code

N - Nervous system

N02 - Analgesics

N02B - Other analgesics and antipyretics

N02BG - Other analgesics and antipyretics

N02BG09 - Methoxyflurane


5.4 Absorption, Distribution and Excretion

Elimination: Primary: 35% excreted unchanged by exhalation.

Thomson.Micromedex. Drug Information for the Health Care Professional. 24th ed. Volume 1. Plus Updates. Content Reviewed by the United States Pharmacopeial Convention, Inc. Greenwood Village, CO. 2004.


Inhalation anesthetics are rapidly absorbed into the circulation via the lungs. /Inhalation anesthetics/

Thomson.Micromedex. Drug Information for the Health Care Professional. 24th ed. Volume 1. Plus Updates. Content Reviewed by the United States Pharmacopeial Convention, Inc. Greenwood Village, CO. 2004.


The urinary fluoride ion concentration was compared in 2 series of parturients, the one receiving methoxyflurane-nitrous oxide analgesia during labor and the other nitrous oxide analgesia. Results showed that in the methoxyflurane-nitrous oxide analgesia series, both the mothers and the neonates showed a significantly higher urinary fluoride ion concentration in comparison to the nitrous analgesia series. The urinary fluoride concentration was related to the vaporized amount of methoxyflurane.

PMID:716954 Dahlgren BE; Acta Pharm Suec 15 (3): 211-7 (1978)


5.5 Metabolism/Metabolites

Hepatic.


Biotransformation - 50% of dose metabolized. A substantial quantity of inorganic fluoride is formed; also metabolized to other potentially nephrotoxic substances.

Thomson.Micromedex. Drug Information for the Health Care Professional. 24th ed. Volume 1. Plus Updates. Content Reviewed by the United States Pharmacopeial Convention, Inc. Greenwood Village, CO. 2004.


5.6 Mechanism of Action

Methoxyflurane induces a reduction in junctional conductance by decreasing gap junction channel opening times and increasing gap junction channel closing times. Methoxyflurane also activates calcium dependent ATPase in the sarcoplasmic reticulum by increasing the fluidity of the lipid membrane. It also appears to bind the D subunit of ATP synthase and NADH dehydogenase. Methoxyflurane also binds to the GABA receptor, the large conductance Ca2+ activated potassium channel, the glutamate receptor and the glycine receptor.


Some halogenated agents, especially methoxyflurane, because of a higher level of fluoride production, induce a renal concentrating defect that could be related to an ascending limb impairment. The mechanisms of fluoride toxicity on an immortalized cell line /was investigated/. Cells were cultured for 2, 6 or 24 hr in the presence of fluoride. Toxicity evaluation was based on: cell numbers, protein content, leucine-incorporation, lactate dehydrogenase (LDH) and N-acetyl-beta-glucosaminidase (NAG) releases, Na-K-ATPase and Na-K-2Cl activities, electron microscope studies. ... At 5 mmol after 24 hr, fluoride decreased cell numbers (-14%, *P < 0.05), protein content (-16%*), leucine incorporation (-54%*), Na-K-2Cl activity (-84%*), increased LDH (+145%*) and NAG release (+190%*). Na-K-ATPase was more sensitive and impaired from 1 mmol for 24hr and after 2 hr at 5 mmol. Crystal formation in mitochondria occurred after 6 hr at 5 mmol. Infra-red analysis and fluoride microdetermination established that crystals contained sodium, phosphate and fluoride. The results suggest that the Na-K-ATPase pump is a major target for fluoride toxicity in Henle's loop.

PMID:12095014 Cittanove ML et al; Eur J Anaesthesiol 19 (5): 341-9 (2002)


The precise mechanism by which inhalation anesthetics produce loss of perception of sensations and unconsciousness is not known. Inhaled anesthetics act at many areas in the CNS. The Meyer-Overton theory suggests that the site of action of inhalation anesthetics may be the lipid matrix of neuronal membranes or other lipophilic sites. Anesthetics may cause changes in membrane thickness, which in turn affect the gating properties of ion channels in neurons. Interference with the hydrophobic portion of neuronal ion channel membrane proteins may be an important mechanism. /Inhalation anesthetics/

Thomson.Micromedex. Drug Information for the Health Care Professional. 24th ed. Volume 1. Plus Updates. Content Reviewed by the United States Pharmacopeial Convention, Inc. Greenwood Village, CO. 2004.


USDMF

read-more
read-more

01

Pharma, Lab & Chemical Expo
Not Confirmed

01

Pharma, Lab & Chemical Expo
Not Confirmed

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 32649

Submission : 2018-06-28

Status : Active

Type : II

blank

02

Pharma, Lab & Chemical Expo
Not Confirmed

02

Pharma, Lab & Chemical Expo
Not Confirmed

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 32648

Submission : 2018-06-28

Status : Active

Type : II

blank

03

Anaquest Inc

Country

USDMF

arrow
Pharma, Lab & Chemical Expo
Not Confirmed

03

Anaquest Inc

Country
arrow
Pharma, Lab & Chemical Expo
Not Confirmed

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 6798

Submission : 1987-01-28

Status : Inactive

Type : II

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

FDA Orange Book

read-more
read-more

01

ABBOTT

U.S.A
Pharma, Lab & Chemical Expo
Not Confirmed
arrow

ABBOTT

U.S.A
arrow
Pharma, Lab & Chemical Expo
Not Confirmed

METHOXYFLURANE

Brand Name : PENTHRANE

Dosage Form : LIQUID; INHALATION

Dosage Strength : 99.9%

Approval Date :

Application Number : 13056

RX/OTC/DISCN :

RLD :

TE Code :

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Canada

read-more
read-more

01

ENDO OPERATIONS LTD.

Country
Pharma, Lab & Chemical Expo
Not Confirmed
arrow

ENDO OPERATIONS LTD.

Country
arrow
Pharma, Lab & Chemical Expo
Not Confirmed

METHOXYFLURANE

Brand Name : PENTHROX

Dosage Form : SOLUTION

Dosage Strength : 99.9%

Packaging : 3ML

Approval Date :

Application Number : 2474719

Regulatory Info :

Registration Country : Canada

blank

02

ENDO OPERATIONS LTD.

Country
Pharma, Lab & Chemical Expo
Not Confirmed
arrow

ENDO OPERATIONS LTD.

Country
arrow
Pharma, Lab & Chemical Expo
Not Confirmed

METHOXYFLURANE

Brand Name : PENTHROX

Dosage Form : SOLUTION

Dosage Strength : 99.9%

Packaging : 3 ML BOTTLE, PENTHROX INHALER, AND ACTIVATED CARBON CHAMBER

Approval Date :

Application Number : 2474727

Regulatory Info :

Registration Country : Canada

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Australia

read-more
read-more

01

Pharma, Lab & Chemical Expo
Not Confirmed
arrow
arrow
Pharma, Lab & Chemical Expo
Not Confirmed

methoxyflurane

Brand Name : Penthrox (Combination Pack)

Dosage Form :

Dosage Strength :

Packaging : 1

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

South Africa

read-more
read-more

01

Pharma, Lab & Chemical Expo
Not Confirmed
arrow
arrow
Pharma, Lab & Chemical Expo
Not Confirmed

Methoxyflurane

Brand Name : Penthrop

Dosage Form : INH

Dosage Strength : 1g/100 ml

Packaging : 3X1% m/m/1,0ml

Approval Date :

Application Number :

Regulatory Info : Originator

Registration Country : South Africa

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

USP

read-more
read-more

01

USP

U.S.A
arrow
Pharma, Lab & Chemical Expo
Not Confirmed

USP

U.S.A
arrow
Pharma, Lab & Chemical Expo
Not Confirmed

Methoxyflurane (0.5 mL)

CAS Number : 76-38-0

Quantity Per Vial :

Price ($) : 230

Catalog Number : 1418004

Current Lot : I0K263

Previous Lot : H0K111 (31-OCT-2013)

NDC Code :

blank

ABOUT THIS PAGE

Methoxyflurane Manufacturers

A Methoxyflurane manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Methoxyflurane, including repackagers and relabelers. The FDA regulates Methoxyflurane manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Methoxyflurane API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

Methoxyflurane Suppliers

A Methoxyflurane supplier is an individual or a company that provides Methoxyflurane active pharmaceutical ingredient (API) or Methoxyflurane finished formulations upon request. The Methoxyflurane suppliers may include Methoxyflurane API manufacturers, exporters, distributors and traders.

click here to find a list of Methoxyflurane suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Methoxyflurane USDMF

A Methoxyflurane DMF (Drug Master File) is a document detailing the whole manufacturing process of Methoxyflurane active pharmaceutical ingredient (API) in detail. Different forms of Methoxyflurane DMFs exist exist since differing nations have different regulations, such as Methoxyflurane USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A Methoxyflurane DMF submitted to regulatory agencies in the US is known as a USDMF. Methoxyflurane USDMF includes data on Methoxyflurane's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Methoxyflurane USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of Methoxyflurane suppliers with USDMF on PharmaCompass.

Methoxyflurane GMP

Methoxyflurane Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Methoxyflurane GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Methoxyflurane GMP manufacturer or Methoxyflurane GMP API supplier for your needs.

Methoxyflurane CoA

A Methoxyflurane CoA (Certificate of Analysis) is a formal document that attests to Methoxyflurane's compliance with Methoxyflurane specifications and serves as a tool for batch-level quality control.

Methoxyflurane CoA mostly includes findings from lab analyses of a specific batch. For each Methoxyflurane CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Methoxyflurane may be tested according to a variety of international standards, such as European Pharmacopoeia (Methoxyflurane EP), Methoxyflurane JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Methoxyflurane USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty